WHO report: cancer risk from Fukushima is low

1 March 2013

'Health Risk Assessment from the nuclear accident after the 2011 Great East Japan Earthquake and Tsunami based on preliminary dose estimation,' released 28 February, said that the lifetime risk for some cancers may be "somewhat elevated" above baseline rates in certain age and sex groups that were in the two areas of Japan most affected.

In terms of specific cancers and for residents of Namie Town and Iitate Village (which received preliminary estimated radiation effective doses of 12 to 25 mSv during the first year), the estimated increased risks over what would normally be expected are:

  • all solid cancers - around 4% in females exposed as infants;
  • breast cancer - around 6% in females exposed as infants;
  • leukaemia - around 7% in males exposed as infants;
  • thyroid cancer - up to 70% in females exposed as infants

The report noted that: "Due to the low baseline rates of thyroid cancer, even a large relative increase represents a small absolute increase in risks." For example, the baseline lifetime risk of thyroid cancer for females is just 0.75% and the additional lifetime risk estimated in this assessment for a female infant exposed in the most affected location is less than 0.50%.

It said that the radiation doses from the damaged nuclear power plant are not expected to cause an increase in the incidence of miscarriages, stillbirths and other physical and mental conditions that can affect babies born after the accident.

It also found that around one-third of emergency workers involved in the Fukushima Daiichi accident would have an increased cancer risk. The remaining two-thirds or workers were estimated to have risks in line with the general population.

The 200-page report is the first analysis of the global health effects due to radiation exposure after the Fukushima accident.



Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.